期刊文献+

益气活血方对系统性红斑狼疮患者血栓前状态改善作用的研究 被引量:7

STUDY ON IMPROVING EFFECT OF YIQI HUOXUE RECIPE ON PRETHROMBOTIC STATE OF PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS
下载PDF
导出
摘要 目的:探讨益气活血方对系统性红斑狼疮患者血栓前状态的改善作用。方法:临床观察单用激素组与并用益气活血方组治疗前后血液流变性及凝血指标的变化.结果:单用激素组治疗后血浆黏度及RBC聚集指数轻度升高,并用益气活血方组治疗后低切全血黏度、红细胞聚集指数、纤维蛋白原等均显著降低,凝血酶原时间(PT)、部分凝血活酶时间(APTT)、凝血酶时间(TT)显著延长。结论:益气活血方能明显改善SLE患者的血栓前状态。 Objective:To observe the improving effect of yiqi huoxue recipe on the prethrombotic state of 102 cases with system lupus erythemalosus.Methods:102 cases with system lupus erythemalosus were divided into two groups,control group was given hormone,treated group was given hormone and Chinese herbs-yiqi huoxue recipe.The hemorheological property was determined by blood viscousmeter.Results:The plasm viscosity and RBC aggregation index were increased in hormone group,the blood viscosity,RBC aggregotion indexes and fibrinogen content were significantly reduced,prothrombin time,partial thromboplastin time and thrombin time were obviously prolonged in yiqi huoxue recipe group.Conclusion:Yiqi huoxue recipe could improve the prethrombotic state of patients with systemic lupus erythematosus and reduce the side effect of hormone.
作者 姚建 赵晓刚
出处 《中国中医药科技》 CAS 2007年第4期238-239,共2页 Chinese Journal of Traditional Medical Science and Technology
  • 相关文献

参考文献3

二级参考文献22

  • 1Boehme MW, Raeth U, Galle PR, et al. Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythmatosus (SEE): advantage over established serological parameters to indicate disease activity. Clin Exp Immunol, 2000, 119: 189-195.
  • 2Junzo N, Hirohiko K, Etsuji S, et al. Anti-prothrombin antibodies combined with lupus anticoagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus. Br J Haemato, 2001, 114: 647-654.
  • 3Frijns CJM, Derksen HWM, de Groot G, et al. Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus. Clin Exp Immunol, 2001, 125: 149-154.
  • 4Dulce C, Caoline OSS, David I, et al. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cellderived mediators, which enhance adhesion molecule expressio
  • 5Cruz D, Keser G, Khamashta MA, et aI. Antiendothelial cell antibodies in inflammatory myopathies:distribution among clinical and serologic groups and association with interstital lung disease.J Rheumatol, 2000, 27: 161-164.
  • 6Pierangeli SS, Espinola RG, Liu X, et al. Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-l, vascular cell adhesion molecule-, and P selectin. Circ Res, 2001, 88: 245-250.
  • 7Gilles R, Patrice C, Catherine F, et al. Increased soluble vascular cell adhesion molecule-1 concentration in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome. Arthritis Rheum, 2000, 43: 55-64.
  • 8Ertenli I, Kiraz S, Haznedaroglu IC, et al. Changes in the concentration and distribution of tissue factor pathway inhibitor in Behcet′ s disease and systemic lupus erythematosus:effect on the prethrombotic state. Inn Rheum Dis, 2001, 60:1 i49-1151.
  • 9Hill MB, Phipps JL, Greaves M. Anti-endothelial cell antibodies in primary antiphospholipid syndrome and SLE. Br J Haemato,1998, 103: 416-421.
  • 10Lockwood CM, Elliott JD, Brettman L, et al. Anti-adhesion molecule therapy as an interventional strategy for autoimmune inflammation. Clin Immunol, 1999, 93: 93-106.

共引文献128

同被引文献131

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部